Key facts
- This page summarizes Jodi Devlin's Form 3 filing for TriSalus Life Sciences, Inc. (TLSI).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 31 Aug 2023, 21:00.
Jodi Devlin - 28 Aug 2023 Form 3 Insider Report for TriSalus Life Sciences, Inc. (TLSI)
- Reporting relationship
- President, Therapeutics
- Issuer ticker
- TLSI
- Reported as of
- 28 Aug 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 31 Aug 2023, 21:00:45 UTC
- Next SEC filing
- 31 Aug 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mary Szela, Attorney-in-Fact for Jodi Devlin
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jodi Devlin filed Form 3 for TriSalus Life Sciences, Inc. (TLSI) on 31 Aug 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.